Search Results - Rashmi Chugh

Refine Results
  1. 1
    Chordoma: The Nonsarcoma Primary Bone Tumor

    Chordoma: The Nonsarcoma Primary Bone Tumor by Rashmi Chugh, Hussein Tawbi, David R. Lucas, J. Sybil Biermann, Scott M. Schuetze, Laurence H. Baker

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Stress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma

    Stress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma by Melanie A. Krook, Lauren Nicholls, Christopher A. Scannell, Rashmi Chugh, Dafydd G. Thomas, Elizabeth R. Lawlor

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases

    Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases by Brittany L. Siontis, Lili Zhao, Monika Leja, Jonathan B. McHugh, Maryann Shango, Laurence H. Baker, Scott M. Schuetze, Rashmi Chugh

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas

    A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas by Andrew J. Wagner, Rashmi Chugh, Lee S. Rosen, Jeffrey A. Morgan, Suzanne George, Michael A. Gordon, Joi Dunbar, Emmanuel Normant, David Grayzel, George D. Demetri

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

    A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors by David C. Smith, Rashmi Chugh, Amita Patnaik, Kyriakos P. Papadopoulos, Min Wang, Ann M. Kapoun, Lu Xu, Jakob Dupont, Robert Stagg, Anthony W. Tolcher

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue Sarcoma

    Phase II Study of 9-Nitro-Camptothecin in Patients With Advanced Chordoma or Soft Tissue Sarcoma by Rashmi Chugh, Rodney L. Dunn, Mark M. Zalupski, J. Sybil Biermann, Vernon K. Sondak, Joseph R. Mace, Kirsten Leu, William F. Chandler, Laurence H. Baker

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors

    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors by David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

    Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Al... by Elizabeth Fox, Shreyaskumar Patel, J. Kyle Wathen, Scott M. Schuetze, Sant P. Chawla, David C. Harmon, Denise K. Reinke, Rashmi Chugh, Robert S. Benjamin, Lee J. Helman

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework

    The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework by J. Sybil Biermann, Geoffrey Siegel, Rashmi Chugh, Jon A. Jacobson, David R. Lucas, Mary Feng, Andrew C. Chang, Sean R. Smith, Sandra L. Wong, Jill M Hasen

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study

    Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study by Herbert I. Hurwitz, David C. Smith, Henry C. Pitot, Jeffrey Mark Brill, Rashmi Chugh, Elisabeth Rouits, Joseph Rubin, John H. Strickler, Grégoire Vuagniaux, John M. Sorensen, Claudio Zanna

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas

    A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas by Jeffrey R. Infante, Philippe A. Cassier, John F. Gerecitano, Petronella O. Witteveen, Rashmi Chugh, Vincent Ribrag, Abhijit Chakraborty, Alessandro Matano, Jason R. Dobson, Adam S. Crystal, Sudha Parasuraman, Geoffrey I. Shapiro

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States

    Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States by Elisabeth A. Pedersen, Rajasree Menon, Kelly M. Bailey, Dafydd G. Thomas, Raelene A. Van Noord, Jenny Tran, Hongwei Wang, Ping Qü, Antje Hoering, Eric R. Fearon, Rashmi Chugh, Elizabeth R. Lawlor

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

    Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model by Rashmi Chugh, J. Kyle Wathen, Robert G. Maki, Robert S. Benjamin, Shreyaskumar Patel, Paul A. Myers, Dennis A. Priebat, Denise K. Reinke, Dafydd G. Thomas, Mary Lou Keohan, Brian L. Samuels, Laurence H. Baker

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing

    The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing by Marcin Cieślik, Rashmi Chugh, Yi-Mi Wu, Ming Wu, Christine Brennan, Robert J. Lonigro, Fengyun Su, Rui Wang, Javed Siddiqui, Rohit Mehra, Xuhong Cao, David R. Lucas, Arul M. Chinnaiyan, Dan R. Robinson

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

    Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial by Rashmi Chugh, J. Kyle Wathen, Shreyaskumar Patel, Robert G. Maki, Paul A. Meyers, Scott M. Schuetze, Dennis A. Priebat, Dafydd G. Thomas, Jon A. Jacobson, Brian L. Samuels, Robert S. Benjamin, Laurence H. Baker

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Asymptomatic SARS-CoV-2 Infection and COVID-19 Mortality During an Outbreak Investigation in a Skilled Nursing Facility

    Asymptomatic SARS-CoV-2 Infection and COVID-19 Mortality During an Outbreak Investigation in a Skilled Nursing Facility by Mahesh Patel, Lelia H. Chaisson, Scott Borgetti, Deborah Burdsall, Rashmi Chugh, Christopher R Hoff, Elizabeth B Murphy, Emily A Murskyj, Shannon Wilson, J. U. Ramos, Lynn Akker, Debra Bryars, Evonda Thomas-Smith, Susan C Bleasdale, Ngozi Ezike

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study

    Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study by Margaret von Mehren, Suzanne George, Michael C. Heinrich, Scott M. Schuetze, Jeffrey T. Yap, J Yu, Amanda Abbott, Samuel Litwin, John Crowley, Martin G. Belinsky, Katherine A. Janeway, Jason L. Hornick, Douglas B. Flieder, Rashmi Chugh, Lori Rink, Annick D. Van den Abbeele

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update

    Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update by Andrew J. Wagner, Vinod Ravi, Richard F. Riedel, Kristen N. Ganjoo, Brian A. Van Tine, Rashmi Chugh, Lee D. Cranmer, Erlinda M. Gordon, Jason L. Hornick, Heng Du, Li Ding, Anita N. Schmid, Willis H. Navarro, David J. Kwiatkowski, Mark A. Dickson

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers

    Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers by Johann S. de Bono, Ramesh K. Ramanathan, Lida A. Mina, Rashmi Chugh, John A. Glaspy, Saeed Rafii, Stan B. Kaye, Jasgit C. Sachdev, John V. Heymach, David C. Smith, Joshua W. Henshaw, Ashleigh Herriott, Miranda Patterson, Nicola J. Curtin, Lauren A. Byers, Zev A. Wainberg

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices

    Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices by Scott D. Ramsey, Joseph M. Unger, Laurence H. Baker, Richard F. Little, Rohit Loomba, Jessica Hwang, Rashmi Chugh, Monica A. Konerman, Kathryn B. Arnold, Alex R. Menter, E D Thomas, Ross M. Michels, Carla Walker Jorgensen, Gary V. Burton, Nishin A. Bhadkamkar, Dawn L. Hershman

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: